國泰君安國際(1788.HK)收漲198.39%,成交164億港元位居港股第一!
國泰君安國際(1788.HK)尾盤漲幅不斷擴大,最終收漲198.39%,報3.7港元,收在全天最高位,全天成交額放大至164億港元,位居港股第一,且爲唯一超百億的個股。國泰君安國際目前的股價逼近2015年6月創出的歷史最高價(3.804港元),有望再創新高。國泰君安國際昨日正式獲得香港證監會批準,將現有證券交易牌照升級爲可提供虛擬資產交易服務及相關諮詢意見。由此,該公司成爲首傢俱備全方位虛擬資產服務能力的香港中資券商,標誌着傳統中資金融機構深度參與虛擬資產交易邁出關鍵一步。


Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.